183 related articles for article (PubMed ID: 9120257)
21. IL-13 has only a subset of IL-4-like activities on B chronic lymphocytic leukaemia cells.
Fluckiger AC; Brière F; Zurawski G; Bridon JM; Banchereau J
Immunology; 1994 Nov; 83(3):397-403. PubMed ID: 7530690
[TBL] [Abstract][Full Text] [Related]
22. Lymphoma models for B-cell activation and tolerance: anti-immunoglobulin M treatment induces growth arrest by preventing the formation of an active kinase complex which phosphorylates retinoblastoma gene product in G1.
Joseph LF; Ezhevsky S; Scott DW
Cell Growth Differ; 1995 Jan; 6(1):51-7. PubMed ID: 7718485
[TBL] [Abstract][Full Text] [Related]
23. Regulation of the catalytic subunit (p34PSK-J3/cdk4) for the major D-type cyclin in mature B lymphocytes.
Tanguay DA; Chiles TC
J Immunol; 1996 Jan; 156(2):539-48. PubMed ID: 8543804
[TBL] [Abstract][Full Text] [Related]
24. Interactions between IL-4, anti-CD40, and anti-immunoglobulin as activators of locomotion of human B cells.
Komai-Koma M; Liew FY; Wilkinson PC
J Immunol; 1995 Aug; 155(3):1110-6. PubMed ID: 7543514
[TBL] [Abstract][Full Text] [Related]
25. Requirements of a costimulus for IL-4-induced IgE class switching in murine B cells activated via antigen receptors: effectiveness of 8-mercaptoguanosine.
Hikida M; Takai T; Ohmori H
J Immunol; 1996 Apr; 156(8):2730-6. PubMed ID: 8609390
[TBL] [Abstract][Full Text] [Related]
26. Epstein-Barr virus exploits the normal cell pathway to regulate Rb activity during the immortalisation of primary B-cells.
Cannell EJ; Farrell PJ; Sinclair AJ
Oncogene; 1996 Oct; 13(7):1413-21. PubMed ID: 8875979
[TBL] [Abstract][Full Text] [Related]
27. The influence of avidity on signaling murine B lymphocytes with monoclonal anti-IgM antibodies. Effects of B cell proliferation versus growth inhibition (tolerance) of an immature B cell lymphoma.
Udhayakumar V; Kumar L; Subbarao B
J Immunol; 1991 Jun; 146(12):4120-9. PubMed ID: 2040794
[TBL] [Abstract][Full Text] [Related]
28. Induction of cell cycle regulatory proteins in anti-immunoglobulin-stimulated mature B lymphocytes.
Solvason N; Wu WW; Kabra N; Wu X; Lees E; Howard MC
J Exp Med; 1996 Aug; 184(2):407-17. PubMed ID: 8760794
[TBL] [Abstract][Full Text] [Related]
29. Anti-CD5 extends the proliferative response of human CD5+ B cells activated with anti-IgM and interleukin-2.
Jamin C; Le Corre R; Lydyard PM; Youinou P
Eur J Immunol; 1996 Jan; 26(1):57-62. PubMed ID: 8566084
[TBL] [Abstract][Full Text] [Related]
30. Anti-CD45 inhibition of human B cell proliferation depends on the nature of activation signals and the state of B cell activation. A study with anti-IgM and anti-CDw40 antibodies.
Gruber MF; Bjorndahl JM; Nakamura S; Fu SM
J Immunol; 1989 Jun; 142(12):4144-52. PubMed ID: 2470814
[TBL] [Abstract][Full Text] [Related]
31. Regulatory effects of IL-4 on human B-cell response to IL-2.
Galanaud P; Karray S; Llorente L
Eur Cytokine Netw; 1990; 1(2):57-64. PubMed ID: 2102812
[TBL] [Abstract][Full Text] [Related]
32. Differential regulatory effects of cAMP-elevating agents on human normal and neoplastic B cell functional response following ligation of surface immunoglobulin and CD40.
Kelly K; Knox KA
Cell Immunol; 1995 Nov; 166(1):93-102. PubMed ID: 7585986
[TBL] [Abstract][Full Text] [Related]
33. Bruton's tyrosine-kinase-deficient murine B lymphocytes fail to enter S phase when stimulated with anti-immunoglobulin plus interleukin-4.
Forssell J; Nilsson A; Sideras P
Scand J Immunol; 1999 Feb; 49(2):155-61. PubMed ID: 10075019
[TBL] [Abstract][Full Text] [Related]
34. IL-4 induces conformational change of CD20 antigen via a protein kinase C-independent pathway. Antagonistic effect of anti-CD40 monoclonal antibody.
Dancescu M; Wu C; Rubio M; Delespesse G; Sarfati M
J Immunol; 1992 Apr; 148(8):2411-6. PubMed ID: 1373168
[TBL] [Abstract][Full Text] [Related]
35. Contrasting effects of interleukin 4 (IL-4) on the in vitro proliferation of human B cells is due to the presence of B cell subsets in different activation states.
De Groot C; Braun J; Mevissen ML; Wormmeester J
Lymphokine Res; 1990; 9(3):321-32. PubMed ID: 2169010
[TBL] [Abstract][Full Text] [Related]
36. Regulation of synthesis and activity of the PLSTIRE protein (cyclin-dependent kinase 6 (cdk6)), a major cyclin D-associated cdk4 homologue in normal human T lymphocytes.
Lucas JJ; Szepesi A; Modiano JF; Domenico J; Gelfand EW
J Immunol; 1995 Jun; 154(12):6275-84. PubMed ID: 7759865
[TBL] [Abstract][Full Text] [Related]
37. B-T cell interactions modulate inhibitory effects of interleukin-4 on human B cell proliferation.
Taieb J; Auffredou MT; Vazquez A
Eur J Immunol; 1994 Feb; 24(2):480-4. PubMed ID: 7507847
[TBL] [Abstract][Full Text] [Related]
38. Blimp-1 overcomes the block in IgM secretion in lipopolysaccharide/anti-mu F(ab')2-co-stimulated B lymphocytes.
Schliephake DE; Schimpl A
Eur J Immunol; 1996 Jan; 26(1):268-71. PubMed ID: 8566078
[TBL] [Abstract][Full Text] [Related]
39. Differential activity of recombinant lymphokines on mouse B cell proliferation and cell cycle progression are revealed by 5-bromo-2'-deoxyuridine/Hoechst 33258 dye flow cytometry.
Seyschab H; Hoehn H; Rabinovitch PS; Chen U
Eur J Immunol; 1991 Sep; 21(9):2153-60. PubMed ID: 1909644
[TBL] [Abstract][Full Text] [Related]
40. CTLA-4-Mediated inhibition of early events of T cell proliferation.
Brunner MC; Chambers CA; Chan FK; Hanke J; Winoto A; Allison JP
J Immunol; 1999 May; 162(10):5813-20. PubMed ID: 10229815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
